ImmuLogic Pharmaceutical Corp. announced that it has filedwith the Securities and Exchange Commission (SEC) for a publicoffering of 2.5 million shares of common stock with anoverallottment option of 375,000 shares. Managingunderwriters for the offering will be Morgan Stanley & Co. Inc.and Hambrecht & Quist Inc.
ImmuLogic of Waltham, Mass., completed a secondary offeringlast January, raising $48.5 million from the sale of 2.1 millionshares at $22.75 a share. The companyLs stock (NASDAQ:IMUL)closed Tuesday at $12.88, down 88 cents a share.
After the current offering, Immulogic will have 14.7 millionshares outstanding.
(c) 1997 American Health Consultants. All rights reserved.